Home NDC 61748-018-60 Rifampin
Product NDC 61748-018
Requested package NDC 61748-018-60
11-digit product format 617480018
Labeler code 61748
Product ID 61748-018_eb950d35-ef45-4f4b-a183-982d7c4d48a7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rifampin
Dosage form CAPSULE
Route ORAL
Labeler Akorn
Application ANDA065028
Marketing category ANDA
Marketing start 2001-07-01
Marketing end 0000-00-00
Substance RIFAMPIN
Active strength 300 mg/1
Pharmacologic classes Rifamycin Antibacterial [EPC], Rifamycins [CS]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065028-001 RIFAMPIN RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 A065028-002 RIFAMPIN RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL 2001-03-14 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL 2001-03-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL AB 2001-03-14 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL AB 2001-03-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL AB 2001-03-14 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL AB 2001-03-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL AB 2001-03-14 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL AB 2001-03-14 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL AB 2001-03-14 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL AB 2001-03-14 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A065028-001 RIFAMPIN 150MG CAPSULE / ORAL AB 2001-03-14 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A065028-002 RIFAMPIN 300MG CAPSULE / ORAL AB 2001-03-14 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 52 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 61748-018-01 2025-09-12 RIFAMPIN CAPSULES, USP 61748-018-11 2025-09-12 RIFAMPIN CAPSULES, USP 61748-018-30 2025-09-12 RIFAMPIN CAPSULES, USP 61748-018-60 2025-09-12 RIFAMPIN CAPSULES, USP 61748-018-01 2024-01-30 RIFAMPIN CAPSULES, USP 61748-018-11 2024-01-30 RIFAMPIN CAPSULES, USP 61748-018-30 2024-01-30 RIFAMPIN CAPSULES, USP 61748-018-60 2024-01-30 RIFAMPIN CAPSULES, USP
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RIFAMPIN ACTIVE INGREDIENT VJT6J7R4TR RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 RIFAMPIN ACTIVE MOIETY VJT6J7R4TR RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 AMMONIA INACTIVE INGREDIENT 5138Q19F1X RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 GELATIN INACTIVE INGREDIENT 2G86QN327L RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 SHELLAC INACTIVE INGREDIENT 46N107B71O RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 TALC INACTIVE INGREDIENT 7SEV7J4R1U RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED] 4 RIFAMPIN ACTIVE INGREDIENT VJT6J7R4TR RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 RIFAMPIN ACTIVE INGREDIENT VJT6J7R4TR RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 RIFAMPIN ACTIVE MOIETY VJT6J7R4TR RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 RIFAMPIN ACTIVE MOIETY VJT6J7R4TR RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 AMMONIA INACTIVE INGREDIENT 5138Q19F1X RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 AMMONIA INACTIVE INGREDIENT 5138Q19F1X RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 SHELLAC INACTIVE INGREDIENT 46N107B71O RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 SHELLAC INACTIVE INGREDIENT 46N107B71O RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT] 2 RIFAMPIN ACTIVE INGREDIENT VJT6J7R4TR RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 RIFAMPIN ACTIVE MOIETY VJT6J7R4TR RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 AMMONIA INACTIVE INGREDIENT 5138Q19F1X RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 DIMETHICONE 410 INACTIVE INGREDIENT TYU5GP6XGE RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 ISOPROPYL ALCOHOL INACTIVE INGREDIENT ND2M416302 RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61748-018 RIFAMPIN CAPSULE [AKORN] 7 Legacy NDC 20220714_26a2dbca-5090-4f6c-99ed-e11a70bb5af0.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 61748-018-60 61748001860 60 CAPSULE in 1 BOTTLE, PLASTIC (61748-018-60) 60 capsule 2001-07-01 0000-00-00 No No Current